 One of the many recent IPOs since the Covid-19 pandemic, PROG stock has encountered numerous setbacks to be a comfortable ride. With their partnership with Avero Diagnotics, management is currently refocusing efforts and resources, seeking strategic alternatives to help the company soar. 